371 related articles for article (PubMed ID: 17611776)
1. Palliative gastrectomy and chemotherapy for stage IV gastric cancer.
Lin SZ; Tong HF; You T; Yu YJ; Wu WJ; Chen C; Zhang W; Ye B; Li CM; Zhen ZQ; Xu JR; Zhou JL
J Cancer Res Clin Oncol; 2008 Feb; 134(2):187-92. PubMed ID: 17611776
[TBL] [Abstract][Full Text] [Related]
2. Role of surgery in the patients with stage I and II primary gastric lymphoma.
Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
[TBL] [Abstract][Full Text] [Related]
3. Chemoresponse after non-curative gastrectomy for M1 gastric cancer.
Shin HB; Lee SH; Son YG; Ryu SW; Sohn SS
World J Surg Oncol; 2015 Jan; 13():13. PubMed ID: 25634223
[TBL] [Abstract][Full Text] [Related]
4. Significance of palliative gastrectomy for late-stage gastric cancer patients.
Chen S; Li YF; Feng XY; Zhou ZW; Yuan XH; Chen YB
J Surg Oncol; 2012 Dec; 106(7):862-71. PubMed ID: 22648960
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
Kinoshita J; Fushida S; Tsukada T; Oyama K; Okamoto K; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Ninomiya I; Ohta T
Eur J Surg Oncol; 2015 Oct; 41(10):1354-60. PubMed ID: 26028256
[TBL] [Abstract][Full Text] [Related]
6. Glasgow prognostic score is a useful predictive factor of outcome after palliative gastrectomy for stage IV gastric cancer.
Mimatsu K; Oida T; Fukino N; Kano H; Kawasaki A; Kida K; Kuboi Y; Amano S
Anticancer Res; 2014 Jun; 34(6):3131-6. PubMed ID: 24922683
[TBL] [Abstract][Full Text] [Related]
7. Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study.
Li Z; Fan B; Shan F; Tang L; Bu Z; Wu A; Zhang L; Wu X; Zong X; Li S; Ren H; Ji J
World J Surg Oncol; 2015 Jul; 13():212. PubMed ID: 26126412
[TBL] [Abstract][Full Text] [Related]
8. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
9. Survival of gastric cancer with concomitant liver metastases.
Kwok CM; Wu CW; Lo SS; Shen KH; Hsieh MC; Lui WY
Hepatogastroenterology; 2004; 51(59):1527-30. PubMed ID: 15362793
[TBL] [Abstract][Full Text] [Related]
10. [Palliative surgery combined with oxaliplatin-based chemotherapy in treatment of patients with advanced gastric cancer].
Chen YB; Guan YX; Zhan YQ; Li W; Sun XW; Li YF; Xu DZ
Ai Zheng; 2004 Nov; 23(11 Suppl):1520-2. PubMed ID: 15566671
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in patients with advanced gastric cancer treated by noncurative resection: a multivariate analysis.
Tsujitani S; Oka S; Suzuki K; Saito H; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Hepatogastroenterology; 2001; 48(41):1504-8. PubMed ID: 11677996
[TBL] [Abstract][Full Text] [Related]
12. Oncologic outcomes of laparoscopy-assisted distal gastrectomy for gastric cancer.
Fukunaga T; Hiki N; Kubota T; Nunobe S; Tokunaga M; Nohara K; Sano T; Yamaguchi T
Ann Surg Oncol; 2013 Aug; 20(8):2676-82. PubMed ID: 23709054
[TBL] [Abstract][Full Text] [Related]
13. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis.
Sun J; Song Y; Wang Z; Chen X; Gao P; Xu Y; Zhou B; Xu H
BMC Cancer; 2013 Dec; 13():577. PubMed ID: 24304886
[TBL] [Abstract][Full Text] [Related]
15. Palliative gastrectomy for advanced gastric cancer.
Hanazaki K; Sodeyama H; Mochizuki Y; Igarashi J; Yokoyama S; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
Hepatogastroenterology; 2001; 48(37):285-9. PubMed ID: 11268986
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
J Surg Oncol; 2012 Jan; 105(1):38-42. PubMed ID: 21882194
[TBL] [Abstract][Full Text] [Related]
17. Palliative distal gastrectomy offers no survival benefit over gastrojejunostomy for gastric cancer with outlet obstruction: retrospective analysis of an 11-year experience.
Okumura Y; Yamashita H; Aikou S; Yagi K; Yamagata Y; Nishida M; Mori K; Nomura S; Kitayama J; Watanabe T; Seto Y
World J Surg Oncol; 2014 Nov; 12():364. PubMed ID: 25432703
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors for development of peritoneal carcinosis in stomach carcinoma].
Jansen M; Büchin P; Dreuw B; Fass J; Minkenberg R; Mehring M; Schumpelick V
Chirurg; 2001 May; 72(5):561-5. PubMed ID: 11383068
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy.
Aoyama T; Yoshikawa T; Hayashi T; Kuwabara H; Mikayama Y; Ogata T; Cho H; Tsuburaya A
Ann Surg Oncol; 2012 May; 19(5):1568-74. PubMed ID: 22143578
[TBL] [Abstract][Full Text] [Related]
20. Extensive gastrectomy and carbon-adsorbed mitomycin C for gastric cancer with peritoneal metastases. Case reports of survivors and their implications.
Hagiwara A; Togawa T; Yamasaki J; Ohgaki M; Imanishi T; Shirasu M; Sakakura C; Yamaguchi T; Sawai K; Yamagishi H
Hepatogastroenterology; 1999; 46(27):1673-7. PubMed ID: 10430319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
